Toggle Nav
Close
  • Menu
  • Setting

BRD4770

Catalog No.
B4837
novel G9a(EHMT2) inhibitor
Grouped product items
SizePriceStock Qty
10mg
$109.00
In stock
50mg
$303.00
In stock
100mg
$506.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

BRD4770 is a histone methyltransferase G9a inhibitor with an IC50 of 6.3 μM and induces cell death[1]. 

In pancreatic cancer cell line PANC-1, BRD4770 reduces intracellular di- and trimethylated H3K9 levels through inhibition of G9a, induces senescence, and inhibits adherent-dependent and independent proliferation[1]. 

Reference:

[1]. Yuan Y, et al. A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma. ACS Chem Biol, 2012, 7(7): 1152-7.

Product Citation

Chemical Properties

Physical AppearanceA crystalline solid
StorageStore at -20°C
M.Wt413.47
Cas No.1374601-40-7
FormulaC25H23N3O3
Solubilityinsoluble in DMSO; insoluble in H2O; insoluble in EtOH
Chemical Namemethyl 2-benzamido-1-(3-phenylpropyl)benzimidazole-5-carboxylate
SDFDownload SDF
Canonical SMILESCOC(=O)C1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC=CC=C3)CCCC4=CC=CC=C4
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control

Chemical structure

BRD4770